Acorda Therapeutics (ACOR) Earnings Date, Estimates & Call Transcripts → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Buy ACOR with Qtrade Free ACOR Stock Alerts $0.66 -0.22 (-24.86%) (As of 04/11/2024) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACOR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACOR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ACOR Earnings Date and InformationAcorda Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Get Acorda Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACOR and its competitors with MarketBeat's FREE daily newsletter. Acorda Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 11/13/2023Q3 2023-($7.16)($7.16)($7.16)-$27.72 million8/8/2023Q2 2023-($7.55)($7.55)($7.55)-$29.68 million5/11/2023Q1 2023-($13.80)($13.80)($13.80)-$22.26 million3/9/2023Q4 2022-$11.40+$11.40$0.57-$31.47 million11/1/2022Q3 2022($2.00)($11.40)($9.40)($0.57)-$33.51 million8/4/2022Q2 2022($7.20)($55.60)($48.40)($2.78)-$31.05 million Get the Latest News and Ratings for ACOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acorda Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2022Q1 2022-($38.60)($38.60)($1.93)-$22.53 million3/9/2022Q4 2021-($34.60)($34.60)($1.73)-$36.97 million11/9/2021Q3 2021($31.20)($28.60)+$2.60($2.43)$30.57 million$31.46 million 8/4/2021Q2 2021($41.80)($37.40)+$4.40($2.29)$29.94 million$31.79 million 5/5/2021Q1 2021($74.20)($49.20)+$25.00($3.53)$22.15 million$28.86 million Acorda Therapeutics Earnings - Frequently Asked Questions When is Acorda Therapeutics's earnings date? Acorda Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on ACOR's earnings history. How much revenue does Acorda Therapeutics generate each year? Acorda Therapeutics (NASDAQ:ACOR) has a recorded annual revenue of $117.63 million. How much profit does Acorda Therapeutics generate each year? Acorda Therapeutics (NASDAQ:ACOR) has a recorded net income of -$252.85 million. ACOR has generated -$203.83 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Scinai Immunotherapeutics Earnings Acorda Therapeutics Earnings SQZ Biotechnologies Earnings Windtree Therapeutics Earnings Gamida Cell Earnings Gamida Cell Earnings Eloxx Pharmaceuticals Earnings Evofem Biosciences Earnings Evelo Biosciences Earnings Neptune Wellness Solutions Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:ACOR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acorda Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.